Johnson and Johnson Vision Care, Inc.

Dsm N.v.

Michael R Clark

Masataka Nakamura

Kazuhiko Fujisawa

Thomas Maggio

Michelle Carman Turnage

Frank F Molock, Jr

Carrie L Caison

Robert N Love

Ryuta Tamiya

Xiaoping Lin

Annie C Maiden

Shivkumar Mahadevan

Gregory A Hill

John C Heaton

Eva Montgomery

Michell Carman Turnage

Jeanette L Ward

Thomas L Maggio

The present invention relates to a silicone acrylamide copolymer of high acrylamide monomer content which has transparency and low modulus, employing the following configuration. The copolymer is suitably used for various kinds of medical devices, particularly ophthalmic lenses such as a contact lens, an intraocular lens, an artificial cornea, and is especially suitable for a contact lens. A copolymer comprising (A) a multi-functional (meth)acrylamide monomer having at least one siloxane bond and at least two (meth)acrylamide groups within a molecule and (B) a mono-functional linear silicone (meth)acrylamide monomer.

Silicone acrylamide copolymer

The present invention relates to a silicone (meth)acrylamide monomer, and this silicone (meth)acrylamide monomer is particularly suitable for use in contact lenses, intraocular lenses, artificial cornea, and the like.

Silicone (meth)acrylamide monomer, polymer, ophthalmic lens, and contact lens

The present invention relates to a process comprising forming a monomer mixture comprising at least one monofunctional silicone containing component which comprises at least one difunctional byproduct and adding to said monomer mixture a normalizing amount of said at least one difunctional byproduct and curing said monomer mixture to form a biomedical device.

Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes

The invention is the method of preparing macromer for use in making ophthalmic lenses comprising combining two or more monomers and using a macromer-forming catalyst, wherein the macromer-forming catalyst comprises triethylamine or bismuth.

Macromer forming catalysts

A radiation-curable coating composition for an optical fiber comprising a reactive functionality-terminated urethane oligomer, wherein said oligomer comprises the reaction product of (i) a semi-crystalline polyol, and (ii) a non-crystalline polyol in the mole ratio of semi-crystalline polyol to non-crystalline polyol of at least about 1:1, (iii) at least one isocyanate, and (iv) an endcapping compound capable of supplying the functionality terminus.

Non-crystal-forming oligomers for use in radiation-curable fiber optice coatings

Growing community of inventors

Jacksonville, FL, United States of America

Michael R Clark